// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Impact of a specialist respiratory pharmacist in the management of interstitial lung disease

Marium Naqvi - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Interstitial lung disease

N/A

Evaluation of ‘care bundles’ as a means of improving hospital care for patients with acute COPD: a case-study approach

Katherine Morton - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Introduction of a Latent TB infection (LTBI) screening programme detects cases of active tuberculosis and hepatitis B and C

Jennifer Yung - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

N/A

Impact of stable state symptoms on the future burden of COPD exacerbations

Alexander Mackay - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

salmeterol + fluticasone

Does nasal rinsing reduce the need for repeat nasal brushing biopsies in a primary ciliary dyskinesia (PCD) diagnostic service? A pilot study.

Amanda Harris - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Primary ciliary dyskinesia

N/A

Prevalence of COPD in heroin smokers attending treatment centres assessed using LLN and relationship to drug consumption

Hassan Burhan - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Tuberculosis

N/A

Clinical features & management of 334 children with primary ciliary dyskinesia in the English National Cohort

Bruna Rubbo - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Primary ciliary dyskinesia

N/A

Analysis of Immunoglobulin A and M gene expression and plasma cells in bronchial tissue from COPD patients with high blood eosinophil counts

Thomas Southworth - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Chronic obstructive pulmonary disease

N/A

Does the nature of adult difficult asthma differ by age of onset? Findings from WATCH.

Heena Mistry - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Impairment of lung organoid formation by cigarette smoke treatment of mesenchymal cells

Padmini P. S. J. Khedoe - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Thapsigargin

An observational study of incident diagnoses of children’s diffuse parenchymal lung disease (ChILDEU)

Steve Cunningham - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A retrospective review of MDT mortality prediction for patients with COPD using The Gold Standard Framework.

Nazra Hussain - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Joint Rheumatology and Chest Clinic in a District General Hospital

Namrata Kewalramani - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Paediatric chronic cough characteristics and aetiology – a retrospective tertiary clinic cohort study

Yury Petrunin - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Spontaneous preterm delivery

N/A

Respiratory readmission rates differ in the year following hospitalisation with RSV and non-RSV bronchiolitis

Gemma Saint - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Human rhinovirus impairs macrophage innate immune responses to bacteria via the interferon pathway in COPD

Lydia Finney - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Interferon

Are lung function abnormalities associated with reduced exercise capacity in prematurely born young people?

Christopher Harris - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Sulfur hexafluoride

What are the determinants in Patient Activation Scores in COPD?

Freddy Frost - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

The effect of an asthma awareness campaign on social media users.

Helmy Haja Mydin - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Indirect airway challenges and asthma related conditions in healthy active individuals

William Gowers - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Copyright © 2026. QuantiNova All rights reserved